Chemistry:YM-254890

From HandWiki
Revision as of 01:06, 6 February 2024 by OrgMain (talk | contribs) (linkage)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Short description: Chemical compound
YM-254890
YM-254890 structure.png
Identifiers
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
ChEMBL
Chemical and physical data
FormulaC46H69N7O15
Molar mass960.092 g·mol−1
3D model (JSmol)

YM-254890 is a macrolide antibiotic derived from Chromobacterium species.[1][2][3][4] It is used as a pharmacological research compound which acts as a selective inhibitor of Gq mediated signalling.[5][6][7][8][9] However the claimed selectivity for Gq has been disputed.[10]

References

  1. "Functions and regulatory mechanisms of Gq-signaling pathways". Neuro-Signals 17 (1): 42–54. 2009. doi:10.1159/000186689. PMID 19212139. 
  2. "Structure, Function, Pharmacology, and Therapeutic Potential of the G Protein, Gα/q,11". Frontiers in Cardiovascular Medicine 2: 14. 2015. doi:10.3389/fcvm.2015.00014. PMID 26664886. 
  3. "Gaq proteins: molecular pharmacology and therapeutic potential". Cellular and Molecular Life Sciences 74 (8): 1379–1390. April 2017. doi:10.1007/s00018-016-2405-9. PMID 27815595. 
  4. "The chromodepsins - chemistry, biology and biosynthesis of a selective Gq inhibitor natural product family". Natural Product Reports 38 (12): 2276–2292. December 2021. doi:10.1039/D1NP00005E. PMID 33998635. 
  5. "Total synthesis and structure-activity relationship studies of a series of selective G protein inhibitors". Nature Chemistry 8 (11): 1035–1041. November 2016. doi:10.1038/nchem.2577. PMID 27768111. Bibcode2016NatCh...8.1035X. 
  6. "Structure-Activity Relationship Studies of the Natural Product Gq/11 Protein Inhibitor YM-254890". ChemMedChem 14 (8): 865–870. April 2019. doi:10.1002/cmdc.201900018. PMID 30790465. 
  7. "Heterotrimeric G Proteins as Therapeutic Targets in Drug Discovery". Journal of Medicinal Chemistry 63 (10): 5013–5030. May 2020. doi:10.1021/acs.jmedchem.9b01452. PMID 31841625. 
  8. "Recent achievements in developing selective Gq inhibitors". Medicinal Research Reviews 40 (1): 135–157. January 2020. doi:10.1002/med.21598. PMID 31218731. 
  9. "Macrocyclic Gq Protein Inhibitors FR900359 and/or YM-254890-Fit for Translation?". ACS Pharmacology & Translational Science 4 (2): 888–897. April 2021. doi:10.1021/acsptsci.1c00021. PMID 33860209. 
  10. "YM-254890 is a General Inhibitor of G Proteins.". The FASEB Journal 33 (S1): 503.7. 2019. doi:10.1096/fasebj.2019.33.1_supplement.503.7.